ZIM Laboratories Limited (NSE:ZIMLAB)
India · Delayed Price · Currency is INR 116.52
-2.06 (-1.74%)
Jul 22, 2026, 3:15 PM IST
ZIM Laboratories Market Cap
ZIM Laboratories has a market cap or net worth of 6.56 billion as of July 22, 2026. Its market cap has increased by 12.61% in one year.
Market Cap
6.56B
Enterprise Value
7.42B
Revenue
3.74B
Ranking
n/a
PE Ratio
112.36
Stock Price
116.52
ChartMarket Cap Chart
Since June 11, 2018, ZIM Laboratories's market cap has increased from 1.68B to 6.56B, an increase of 290.07%. That is a compound annual growth rate of 18.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 6.56B | 87.23% |
| Dec 31, 2025 | 3.50B | -33.11% |
| Dec 31, 2024 | 5.24B | -6.72% |
| Dec 29, 2023 | 5.62B | 18.57% |
| Dec 30, 2022 | 4.74B | 146.60% |
| Dec 31, 2021 | 1.92B | 31.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beta Drugs | 24.62B |
| Indoco Remedies | 22.57B |
| Ind-Swift Laboratories | 20.29B |
| Sakar Healthcare | 20.00B |
| Windlas Biotech | 17.99B |
| Jagsonpal Pharmaceuticals | 14.97B |
| Sigachi Industries | 9.75B |
| Bafna Pharmaceuticals | 5.42B |